Comprehensive metabolomic studies on the Fmr1-KO mouse model of FXS have demonstrated region-specific metabolic profiles, with the cerebellum and cerebral cortex being particularly affected [25]. The gene discussed is FMR1; the disease is fragile X syndrome.